GALECTIN THERAPEUTICS INC (GALT) Net Cash Provided by (Used in) Investing Activities USD 2011 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Galectin Therapeutics Inc annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2011 to 2023.
  • Galectin Therapeutics Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2014 was -$400 K.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2023 was $0.000.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was $0.000.
  • Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2021 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2019-03-06
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2012 $64 K +$79 K Jan 1, 2012 Dec 31, 2012 10-K 2014-03-21
2011 -$15 K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.